Technical Trading Overview for China Automotive Systems Inc. (CAAS)

November 19, 2009

China Automotive Systems Inc. (NASDAQ: CAAS)

China Automotive Systems Inc. (CAAS), through its interests in Sino-foreign joint ventures, engages in the manufacture and sale of automotive systems and components for the automobile industry in the People’s Republic of China. The Company offers automotive parts, power steering gears, automotive steering gears, steering pumps, sensor modular and electric power steering. It also offers integral power steering gear and pinion power steering gear for light and heavy-duty vehicles and cars. Read more

Popularity: unranked [?]

Technical Trading Overview for Excel Maritime Carriers Ltd. (EXM)

November 19, 2009

Excel Maritime Carriers Ltd. (NYSE: EXM)

Excel Maritime Carriers Ltd. (EXM) is a provider of worldwide sea borne transportation services for dry bulk cargo, including among others, iron ore, coal and grain, collectively referred to as major bulks, and steel products, fertilizers, cement, bauxite, sugar and scrap metal, collectively referred to as minor bulks. EXM’s fleet is managed by one of its wholly owned subsidiaries, Maryville Maritime Inc. (Maryville). As of April 27, 2009, the Company owned a fleet of 40 vessels, and together with seven Panamax vessels under bareboat charters, operates 47 vessels, five Capesize, 14 Kamsarmax, 21 Panamax, two Supramax and five Handymax, with a total carrying capacity of approximately 3.9 million deadweight tons (dwt). On April 15, 2008, the Company completed its acquisition of Quintana Maritime Ltd. (Quintana). As a result of the acquisition, Quintana operates as a wholly owned subsidiary of Excel under the name Bird. Read more

Popularity: unranked [?]

Trading Outlook for Bergio International Inc. (BRGO)

November 19, 2009

Bergio International Inc. (OTCBB: BRGO)

The Company (BRGO) was incorporated on July 24, 2007 as Alba Mineral Exploration Inc. The Company formed its wholly owned subsidiary, Alba Mineral Exploration Inc., an Alberta corporation, which was formed to conduct the Company’s originally planned mineral exploration on the Crow Hill mineral claim located on the Baie Verte Peninsula on Newfoundland Island, Canada. Read more

Popularity: unranked [?]

Technical Trading Overview for Sinobiopharma Inc. (SNBP)

November 18, 2009

Sinobiopharma Inc. (OTCBB: SNBP)

Sinobiopharma Inc. (SNBP) is an emerging, fully integrated and highly innovative biotechnology company engaged in the research and development, manufacture and marketing of biopharmaceutical products in China, the world’s fastest growing pharmaceutical market. Known as Dong Ying (Jiangsu) Pharmaceutical Co. Ltd. in China, the Company’s current therapeutic focus is on anesthesia-assisted agents and cardiovascular drugs. SNBP’s flagship – drug Cisatracurium besylate – captured 65% of the Chinese market within 14 months of launch. GlaxoSmithKline sells its version of the drug globally for $22 per injection. The Company profitably sells its formulation in China for under $5. The Company will be applying for a U.S. and international patent and intends to market its API and new formulation worldwide and in the U.S. when the patent on GSK’s version expires there in 2010. Read more

Popularity: unranked [?]

Technical Trading Overview for Playboy Enterprises Inc. (PLA)

November 18, 2009

Playboy Enterprises Inc. (NYSE: PLA)

Playboy Enterprises Inc. (PLA) is a media entertainment and lifestyle company. The Company’s programming and content is available worldwide on television networks, Websites, mobile platforms and radio. Playboy operates in three segments: Entertainment, Publishing and Licensing. The Entertainment Group operations include the production, marketing and sales of programming under the Playboy, Spice and other brand names, which are distributed through various channels, including domestic and international television (TV), Internet, wireless and satellite radio. Its Publishing Group operations include the publication of Playboy magazine, special editions and other domestic publishing businesses, including books and calendars, and the licensing of international editions of Playboy magazine. The Company’s Licensing Group operations include the licensing of consumer products carrying one or more of its trademarks and/or images, Playboy-branded retail stores, multifaceted location-based entertainment venues and certain revenue-generating marketing activities. Read more

Popularity: unranked [?]

Technical Trading Overview for Arena Pharmaceuticals Inc. (ARNA)

November 17, 2009

Arena Pharmaceuticals Inc. (NASDAQ: ARNA)

Arena Pharmaceuticals Inc. (ARNA) is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases. The Company’s drug candidate, lorcaserin hydrochloride (lorcaserin), is being investigated in a phase III clinical trial program for the treatment of obesity. It has a pipeline of compounds that target G protein-coupled receptors (GPCRs), and includes compounds being evaluated independently and with its partners, including Merck & Co. Inc. and Ortho-McNeil-Janssen Pharmaceuticals Inc. On January 9, 2008, the Company acquired from Siegfried Ltd. certain drug product facility assets, including a licensed production facility, fixtures, equipment, other personal property and real estate assets in Zofingen, Switzerland. Read more

Popularity: unranked [?]

Clicky Web Analytics